<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SECPFBQW/ca8df46c-70ba-4b3f-b79e-b93c279f86bb/HTML"><dcterms:extent>26 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SECPFBQW/17c5c28b-c894-4689-96c2-e8da4902cc5c/PDF"><dcterms:extent>87 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-SECPFBQW/68721fa3-3c66-41d4-afcc-9c72690b09f1/TEXT"><dcterms:extent>22 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1998-2025"><edm:begin xml:lang="en">1998</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-SECPFBQW"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-KC6O72BG" /><dcterms:issued>2011</dcterms:issued><dc:creator>Borštnar, Simona</dc:creator><dc:creator>Debeljak, Nataša</dc:creator><dc:creator>Komel, Radovan</dc:creator><dc:creator>Matos, Erika</dc:creator><dc:creator>Možina, Barbara</dc:creator><dc:creator>Sytkowski, Arthur J.</dc:creator><dc:creator>Španinger, Klemen</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:58</dc:format><dc:format xml:lang="sl">str. 139-143</dc:format><dc:identifier>ISSN:1318-0207</dc:identifier><dc:identifier>COBISSID:28208345</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-SECPFBQW</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Slovenian Chemical Society</dc:publisher><dc:publisher xml:lang="sl">Slovensko kemijsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta chimica slovenica</dcterms:isPartOf><dc:subject xml:lang="en">Blood</dc:subject><dc:subject xml:lang="en">Breast Neoplasms</dc:subject><dc:subject xml:lang="en">Cisplatin</dc:subject><dc:subject xml:lang="sl">Dojka, novotvorbe</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="sl">Eritrociti, štetje</dc:subject><dc:subject xml:lang="sl">eritropoeza</dc:subject><dc:subject xml:lang="en">Eritropoietin</dc:subject><dc:subject xml:lang="sl">Eritropoietin rekombinantni</dc:subject><dc:subject xml:lang="en">Erythrocyte Count</dc:subject><dc:subject xml:lang="en">Erythropoietin</dc:subject><dc:subject xml:lang="en">Erythropoietin, Recombinant</dc:subject><dc:subject xml:lang="sl">Hemoglobini</dc:subject><dc:subject xml:lang="en">Hemoglobins</dc:subject><dc:subject xml:lang="en">Immunoblotting</dc:subject><dc:subject xml:lang="sl">Imunoblot</dc:subject><dc:subject xml:lang="en">Isoelectric Focusing</dc:subject><dc:subject xml:lang="sl">Izoelektrični fokusing</dc:subject><dc:subject xml:lang="en">Urine</dc:subject><dcterms:temporal rdf:resource="1998-2025" /><dc:title xml:lang="sl">Report on isoelectric focusing trial of erythropoietin profiling in two cancerpatients during chemotherapy and darbepoetin treatment|</dc:title><dc:description xml:lang="sl">The level of erythropoietin, main regulator of erythropoiesis, is affected by hypoxia, anaemia, application of recombinant erythropoietin, chemotherapy and others. Isoelectric focusing (IEF) combined with double immunobloting is a method that enables distinct analysis of endogenous and recombinant erythropoietin isoforms. Aim of our study was to set up analysis of treatment effects on the pattern of endogenous erythropoietin in anaemic breast cancer patient. Urine and blood samples were collected during and after termination of the treatment and analysed by isoelectric focusing. Endogenous erythropoietin was found lower, but still detectable during darbepoetin treatment. Normal shift of erythropoietin isoforms between serum vs. urine, ordinary seen in healthy volunteers, was not observed indicating kidney damage. The patient was suffering from heavy proteinuria and had low Glomerular filtration rate indicating acute renal failure, probably caused by clinical status or cisplatin chemotherapy. IEF has not yet been used for follow up of erythropoietin profile in cancer patients. It enables to monitor the effects of treatment on the level of endogenous erythropoietin and indirectly indicates kidney function</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-SECPFBQW"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-SECPFBQW" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-SECPFBQW/17c5c28b-c894-4689-96c2-e8da4902cc5c/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko kemijsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-SECPFBQW/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-SECPFBQW" /></ore:Aggregation></rdf:RDF>